DUXIL

Dose: 3 mg/kg
Single Dose: 3 (3)
Frequency: As recommended.
Route: IV Inf
Instructions: For 2 hours, in 2-3 div.doses.

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Synthetic origin and belongs to Methanesulfonate. It belongs to Vasotherapeutics pharmacological group.The Molecular Weight of Almitrine is 669.80. Its pKa is 4, 5.

Almitrine is contraindicated in conditions like Hepatic failure,Restrictive lung disease,Primary heart disease.

The severe or irreversible adverse effects of Almitrine, which give rise to further complications include Peripheral neuropathy.The signs and symptoms that are produced after the acute overdosage of Almitrine include Hyperventilation, Hypocapnia.The symptomatic adverse reactions produced by Almitrine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Vertigo, Drowsiness, Irritability, Nausea, Anxiety, Dyspnea, Palpitation, Insomnia, Weight LossX, Burning, Epigastric pain, Increased intracranial pressure, GI disturbance, Heaviness.

Almitrine is primarily indicated in conditions like Acute exacerbation of hypoxic coadaptation, Chronic respiratory failure in hypoxic load, Respiratory depression after anesthesia, Respiratory depression after drug overdose.

No data regarding the interactions of Almitrine was found.

Drug should not be given to Pregnant Mothers, and patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab, Vial

Almitrine should be used with caution in patient with hepatic disease. The best mean of achieving and maintaining therapeutic levels without toxic accumulation is by intrmittent dosing, this avoid the accumulation of drug on continuous dosing.